Ligand ID: T1C Drugbank ID: DB00560(Tigecycline) Indication:For the treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates only), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes and Bacteroides fragilis. Complicated intra-abdominal infections caused by Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates only), Staphylococcus aureus (methicillin-susceptible isolates only), Streptococcus anginosus grp. (includes S. anginosus, S. intermedius, and S. constellatus), Bacteroides fragilis, Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, Clostridium perfringens, and Peptostreptococcus micros. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 498PHE B 497GLY B 447SER B 443GLY B 504 | 1.61A | 20.00 | None | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6m17 | ACE2RECEPTOR BINDINGDOMAIN (Homosapiens;SARS-CoV-2) | 5 / 11 | ASP B 38ASN E 439GLN E 506GLY E 502GLY E 447 | 1.79A | 18.72 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE C 3HIS A 172GLY C 2ALA C 7GLY A 124 | 1.75A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | THR C 169HIS C 172GLY C 138ALA A 211GLY A 215 | 1.75A | 22.80 | None | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE B 3HIS D 172GLY B 2ALA B 7GLY D 124 | 1.78A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE B 3HIS D 172GLY B 2ALA B 7GLY D 124 | 1.79A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 3HIS C 172GLY A 2ALA A 7GLY C 124 | 1.76A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | THR D 169HIS D 172GLY D 138ALA B 211GLY B 215 | 1.78A | 22.80 | None | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE D 3HIS B 172GLY D 2ALA D 7GLY B 124 | 1.74A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE D 3HIS B 172GLY D 2ALA D 7GLY B 124 | 1.76A | 22.80 | None | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE C 3HIS A 172GLY C 2ALA C 7GLY A 124 | 1.73A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | THR A 169HIS A 172GLY A 138ALA C 211GLY C 215 | 1.63A | 22.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | THR B 169HIS B 172GLY B 138ALA D 211GLY D 215 | 1.56A | 22.80 | None | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | PHE A 3HIS C 172GLY A 2ALA A 7GLY C 124 | 1.75A | 22.80 | None | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 148PRO A 118ALA D 153GLY A 121ASN D 151 | 1.31A | 22.83 | None | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 11 | GLY A 148PRO A 118ALA D 153GLY A 121ASN D 151 | 1.44A | 17.98 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 769PHE A 753HIS A 613ALA A 706GLY A 774 | 1.69A | 17.25 | None | ||
![]() | 4A6N_B_T1CB392_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.51A | 16.57 | NoneNoneNAG A1304 (-1.8A)NoneNone | ||
![]() | 3V3O_D_T1CD401_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.49A | 16.41 | NoneNoneNAG A1304 (-1.8A)NoneNone | ||
![]() | 4A6N_C_T1CC392_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.49A | 16.57 | NoneNoneNAG A1304 (-1.8A)NoneNone | ||
![]() | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER A 758GLN C 957THR C 961GLN A 762LEU A1012 | 1.68A | 10.39 | None | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.49A | 16.65 | NoneNoneNAG A1304 (-1.8A)NoneNone | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLN A 613GLY A 594ALA B 766GLY B 769GLN B 762 | 1.46A | 16.41 | None | ||
![]() | 4A6N_D_T1CD392_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.49A | 16.57 | NoneNoneNAG A1304 (-1.8A)NoneNone | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.52A | 16.41 | NoneNoneNAG A1304 (-1.8A)NoneNone | ||
![]() | 4A6N_B_T1CB392_1 (TETX2 PROTEIN) | 6vww | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | PHE B 135ASN B 137GLY B 141GLY B 126GLU B 146 | 1.73A | 27.39 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6vww | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | ASN B 9HIS B 15GLY B 14ALA B 55ASN B 46 | 1.47A | 23.63 | None | ||
![]() | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER C 758GLN B 957THR B 961GLN C 762LEU C1012 | 1.67A | 10.08 | None | ||
![]() | 3V3O_D_T1CD401_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | GLN C 920PHE C 898ASN B 709GLY C 799MET C1050 | 1.47A | 16.18 | NoneNoneNAG B1311 (-1.9A)NoneNone | ||
![]() | 4A6N_C_T1CC392_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN C 920PHE C 898ASN B 709GLY C 799MET C1050 | 1.51A | 16.38 | NoneNoneNAG B1311 (-1.9A)NoneNone | ||
![]() | 4A6N_B_T1CB392_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN C 920PHE C 898ASN B 709GLY C 799MET C1050 | 1.53A | 16.38 | NoneNoneNAG B1311 (-1.9A)NoneNone | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLN A 920PHE A 898ASN C 709GLY A 798MET A1050 | 1.50A | 16.18 | NoneNoneNAG C1311 (-1.9A)NoneNone | ||
![]() | 4A6N_D_T1CD392_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | GLN C 920PHE C 898ASN B 709GLY C 799MET C1050 | 1.51A | 16.38 | NoneNoneNAG B1311 (-1.9A)NoneNone | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN C 920PHE C 898ASN B 709GLY C 799MET C1050 | 1.52A | 16.46 | NoneNoneNAG B1311 (-1.9A)NoneNone | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | THR C1066GLN C 926ALA A 892GLY A 891GLN A 787 | 1.34A | 16.18 | NoneNAG C1312 ( 4.9A)NoneNoneNone | ||
![]() | 4A6N_D_T1CD392_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.52A | 16.46 | NoneNoneNAG A1311 (-1.9A)NoneNone | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | THR A1027ARG C1039GLY C1044ALA C1025GLN C 784 | 1.35A | 16.26 | None | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.52A | 16.54 | NoneNoneNAG A1311 (-1.9A)NoneNone | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLN B 920PHE B 898ASN A 709GLY B 798MET B1050 | 1.47A | 16.26 | NoneNoneNAG A1311 (-1.9A)NoneNone | ||
![]() | 4A6N_C_T1CC392_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.51A | 16.46 | NoneNoneNAG A1311 (-1.9A)NoneNone | ||
![]() | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | SER A 758GLN C 957THR C 961GLN A 762LEU A1012 | 1.54A | 10.08 | None | ||
![]() | 4A6N_B_T1CB392_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.53A | 16.46 | NoneNoneNAG A1311 (-1.9A)NoneNone | ||
![]() | 3V3O_D_T1CD401_1 (TETX2 PROTEIN) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | GLN B 920PHE B 898ASN A 709GLY B 799MET B1050 | 1.46A | 16.26 | NoneNoneNAG A1311 (-1.9A)NoneNone | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6w01 | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 241HIS B 235GLY B 247ALA B 256GLY B 254 | 1.48A | 23.63 | NoneCIT B 408 (-4.2A)CIT B 408 (-3.1A)NoneNone | ||
![]() | 4A6N_C_T1CC392_1 (TETX2 PROTEIN) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 11 | GLN C 498PHE C 497GLY C 447SER C 443GLY C 504 | 1.53A | 14.71 | None | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w4h | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4323MET A6839 | 1.54A | 15.83 | NoneNoneSAM A7102 ( 4.5A)NoneBDF B4403 (-4.8A) | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4322MET A6839 | 1.57A | NoneNoneSAM A7104 (-4.4A)NoneNone | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6w61 | NSP10 (SARS-CoV-2) | 5 / 11 | ARG B4331PHE B4321GLY B4322GLY B4362ASN B4358 | 1.78A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR A6915PHE A6954GLY A6953ALA A6919ASN A6920 | 1.79A | None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4323MET A6839 | 1.49A | NoneNoneSAM A7104 (-4.4A)NoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS D4333GLY C6875SER C6872GLY D4323MET C6839 | 1.42A | 15.83 | NoneNoneSAM C7105 ( 4.4A)NoneNone | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4322MET A6839 | 1.49A | 15.83 | NoneNoneSAM A7102 ( 4.6A)NoneNone | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | THR C6915PHE C6954GLY C6953ALA C6919ASN C6920 | 1.69A | 17.59 | NoneNoneNoneNoneFMT C7106 ( 4.1A) | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6w75 | NSP10 (SARS-CoV-2) | 5 / 11 | ARG B4331PHE B4321GLY B4322GLY B4362ASN B4358 | 1.78A | 15.18 | NoneNoneNoneNone NA B4403 ( 3.4A) | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6w75 | NSP10 (SARS-CoV-2) | 5 / 11 | ARG D4331PHE D4321GLY D4322GLY D4362ASN D4358 | 1.76A | 15.18 | None | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS D4333GLY C6875SER C6872GLY D4322MET C6839 | 1.47A | 15.83 | NoneNoneSAM C7105 ( 4.4A)NoneNone | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4323MET A6839 | 1.46A | 15.83 | NoneNoneSAM A7102 ( 4.6A)NoneNone | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | THR A6915PHE A6954GLY A6953ALA A6919ASN A6920 | 1.71A | 17.59 | NoneNoneNoneNoneFMT A7106 ( 4.0A) | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | PHE C 173ASN C 128HIS C 175MET C 243GLN C 237 | 1.70A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | PHE A 173ASN A 128HIS A 175MET A 243GLN A 237 | 1.60A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | PHE B 173ASN B 128HIS B 175MET B 243GLN B 237 | 1.63A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132ASN A 101ALA A 50GLY A 48ASN A 37 | 1.78A | MES A 201 (-2.5A)NoneMES A 201 ( 3.0A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE F 315GLY F 316ALA E 336GLY E 335GLN F 260 | 1.69A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE E 315GLY E 316ALA F 336GLY F 335GLN E 260 | 1.65A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 315GLY A 316ALA B 336GLY B 335GLN A 260 | 1.66A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR E 332GLN E 281ALA E 336GLY E 335GLN F 260 | 1.69A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR B 332GLN B 281ALA B 336GLY B 335GLN A 260 | 1.69A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE B 315GLY B 316ALA A 336GLY A 335GLN B 260 | 1.62A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE C 315GLY C 316ALA D 336GLY D 335GLN C 260 | 1.65A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE D 315GLY D 316ALA C 336GLY C 335GLN D 260 | 1.64A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR D 332GLN D 281ALA D 336GLY D 335GLN C 260 | 1.75A | None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS D4333GLY C6875SER C6872GLY D4322MET C6839 | 1.38A | NoneNoneSAH C7102 (-4.7A)NoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS D4333GLY C6875SER C6872GLY D4323MET C6839 | 1.32A | NoneNoneSAH C7102 (-4.7A)NoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4322MET A6839 | 1.37A | NoneNoneSAH A7102 ( 4.6A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR C6915PHE C6954GLY C6953ALA C6919ASN C6920 | 1.76A | FMT C7107 (-3.7A)NoneNoneNoneFMT C7103 (-4.0A) | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4323MET A6839 | 1.36A | NoneNoneSAH A7102 ( 4.6A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR A6915PHE A6954GLY A6953ALA A6919ASN A6920 | 1.68A | NoneNoneNoneNoneFMT A7106 (-3.8A) | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wjt | NSP10 (SARS-CoV-2) | 5 / 11 | ARG D4331PHE D4321GLY D4322GLY D4362ASN D4358 | 1.77A | None | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wjt | NSP10 (SARS-CoV-2) | 5 / 11 | ARG B4331PHE B4321GLY B4322GLY B4362ASN B4358 | 1.78A | None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 11 | ASP C 144ASN C 75ARG B 107HIS B 59GLY C 147 | 1.60A | NoneNoneNone ZN C 201 (-3.3A)None | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ASN D 126GLY D 129PRO D 117ALA D 119GLY D 120 | 1.63A | 17.80 | None | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 126GLY B 129PRO B 117ALA B 119GLY B 120 | 1.58A | 17.80 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | THR A6915PHE A6954GLY A6953ALA A6919ASN A6920 | 1.71A | NoneNoneNoneNoneFMT A7109 ( 3.9A) | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS D4333GLY C6875SER C6872GLY D4323MET C6839 | 1.39A | NoneNoneSFG C7103 ( 4.5A)NoneNone | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wkq | NSP10 (SARS-CoV-2) | 5 / 11 | ARG B4331PHE B4321GLY B4322GLY B4362ASN B4358 | 1.77A | None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4322MET A6839 | 1.41A | NoneNoneSFG A7103 ( 4.5A)NoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS D4333GLY C6875SER C6872GLY D4322MET C6839 | 1.43A | NoneNoneSFG C7103 ( 4.5A)NoneNone | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wkq | NSP10 (SARS-CoV-2) | 5 / 11 | ARG D4331PHE D4321GLY D4322GLY D4362ASN D4358 | 1.76A | None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4323MET A6839 | 1.39A | NoneNoneSFG A7103 ( 4.5A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | THR C6915PHE C6954GLY C6953ALA C6919ASN C6920 | 1.73A | NoneNoneNoneNoneFMT C7106 ( 4.1A) | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 241HIS B 235GLY B 247ALA B 256GLY B 254 | 1.51A | 25.48 | None | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | ARG B 136PHE B 135ASN B 137GLY B 141ASN B 178 | 1.79A | NoneNoneNoneNoneACT B 407 (-3.5A) | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 241HIS A 235GLY A 247ALA A 256GLY A 254 | 1.51A | 25.48 | None | ||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | PHE A 135ASN A 137GLY A 141GLY A 126ASN A 178 | 1.73A | None | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | ARG A 136PHE A 135ASN A 137GLY A 141ASN A 178 | 1.77A | None | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 11 | PHE B 135ASN B 137GLY B 141GLY B 126ASN B 178 | 1.72A | NoneNoneNoneACT B 408 (-4.2A)ACT B 407 (-3.5A) | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE B 135ASN B 137GLY B 141GLY B 126ASN B 178 | 1.78A | 25.48 | NoneNoneNoneACT B 408 (-4.2A)ACT B 407 (-3.5A) | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | PHE A 135ASN A 137GLY A 141GLY A 126ASN A 178 | 1.78A | 25.48 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR B 149ASN B 117ALA C 50GLY C 51ASN C 37 | 1.47A | NoneNoneAPR C 201 (-3.5A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR D 149ASN D 117ALA A 50GLY A 48ASN A 37 | 1.32A | NoneNoneAPR A 201 (-3.4A)APR A 201 (-3.5A)None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR B 149ASN B 117ALA C 50GLY C 47ASN C 37 | 1.51A | NoneNoneAPR C 201 (-3.5A)APR C 201 (-4.1A)None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR B 149ASN B 117ALA C 50GLY C 48ASN C 37 | 1.37A | NoneNoneAPR C 201 (-3.5A)APR C 201 (-3.5A)None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR D 149ASN D 117ALA A 50GLY A 51ASN A 37 | 1.44A | NoneNoneAPR A 201 (-3.4A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR D 149ASN D 117ALA A 50GLY A 47ASN A 37 | 1.48A | NoneNoneAPR A 201 (-3.4A)APR A 201 (-4.1A)None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4323MET A6839 | 1.39A | NoneNoneSO4 A7109 (-4.5A)NoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 11 | HIS B4333GLY A6875SER A6872GLY B4322MET A6839 | 1.50A | NoneNoneSO4 A7109 (-4.5A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | PHE A 173ASN A 128HIS A 175MET A 243GLN A 237 | 1.64A | NonePO4 A 504 (-3.7A)PO4 A 504 (-3.8A)NoneNone | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | PHE A 173ASN A 128HIS A 175GLY A 201MET A 243 | 1.80A | 20.00 | NonePO4 A 504 (-3.7A)PO4 A 504 (-3.8A)NoneNone | ||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | PHE A 173ASN A 128HIS A 175ALA A 204GLY A 201 | 1.42A | 20.00 | NonePO4 A 504 (-3.7A)PO4 A 504 (-3.8A)NoneNone | ||
![]() | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | HIS C 36ARG B 80THR B 89LEU A 20SER A 15 | 1.74A | 17.50 | None | ||
![]() | 4A6N_C_T1CC392_1 (TETX2 PROTEIN) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 11 | GLN E 498PHE E 497GLY E 447SER E 443GLY E 504 | 1.78A | 20.42 | None | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 6 / 12 | THR C 57ASN C 87HIS C 86ALA D 50GLY D 51ASN D 37 | 1.79A | NoneNoneNoneEDO D 206 (-3.6A)NoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN A 115GLN D 118HIS D 119SER A 80GLY D 78 | 1.78A | EDO D 201 (-3.4A)EDO D 201 ( 4.4A)NoneNoneNone | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN D 115GLN A 118HIS A 119SER D 80GLY A 78 | 1.78A | EDO D 201 (-3.6A)EDO D 201 ( 4.5A)NoneNoneNone | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN E 101GLY B 130PRO B 125ALA B 154GLU B 26 | 1.63A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146GLN D 118ASN A 117ALA A 38ASN A 37 | 1.49A | NoneEDO D 201 ( 4.4A)NoneEDO A 202 (-3.3A)None | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 87HIS C 86ALA D 50GLY D 51ASN D 37 | 1.70A | 19.83 | NoneNoneEDO D 206 (-3.6A)NoneNone | ||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN A 115GLN D 118HIS D 119SER A 80GLY D 78 | 1.79A | EDO A 207 (-3.9A)EDO A 207 ( 4.7A)NoneNoneNone | |||
![]() | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN E 101GLY B 130PRO B 125ALA B 154GLU B 26 | 1.64A | NoneAPR B 201 (-3.2A)NoneAPR B 201 (-4.5A)None | |||
![]() | 3V3O_B_T1CB405_1 (TETX2 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | ASN C 87HIS C 86ALA D 50GLY D 51ASN D 37 | 1.66A | 19.83 | NoneNoneAPR D 201 (-3.6A)NoneNone | ||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 6 / 12 | THR C 57ASN C 87HIS C 86ALA D 50GLY D 51ASN D 37 | 1.72A | NoneNoneNoneAPR D 201 (-3.6A)NoneNone | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146GLN D 118ASN A 117ALA A 38ASN A 37 | 1.49A | NoneEDO A 207 ( 4.7A)NoneAPR A 201 (-3.4A)None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN C 115GLN A 118HIS A 119SER C 80GLY A 78 | 1.75A | EDO A 202 (-3.6A)EDO A 202 (-4.6A)NoneEDO A 204 ( 4.9A)None | |||
![]() | 3V3O_C_T1CC401_1 (TETX2 PROTEIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 11 | ASN A 115GLN C 118HIS C 119SER A 80GLY C 78 | 1.76A | EDO A 202 ( 3.5A)EDO A 204 (-4.1A)NoneEDO A 204 (-3.3A)None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 769PHE A 753HIS A 613ALA A 706GLY A 774 | 1.74A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 769PHE A 753HIS A 613ALA A 706GLY A 774 | 1.65A | None | |||
![]() | 3V3O_A_T1CA404_1 (TETX2 PROTEIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 769PHE A 753HIS A 613ALA A 706GLY A 774 | 1.75A | None |